Skip to main content

Table 1 Patient characteristics

From: Endothelium-derived microparticles from chronically thromboembolic pulmonary hypertensive patients facilitate endothelial angiogenesis

 

Healthy

CTEPH

PE

N = 4

N = 6

N = 6

Males/females

2/2

2/4

2/4

Age, years

54 (42–60)

68 (52–81)

68 (45–91)

mPAP, mmHg

-

42 (30–57)

-

Warfarin/anticoagulants

-

6

6

Ca channel blockers

-

1

1

statins

-

2

2

paracetamol/aspirin

-

3

4

ET-1 antagonists

-

5

-

Diuretics

-

4

1

ACE inhibitors

-

2

1

Angiotensin II antagonists

-

-

1

β-blockers

-

1

4